Reminiscences from Indian pediatrics: a
tale of 50 years |
|
Indian Pediatr 2017;54: 961-962 |
 |
Current Perspective on Exchange Transfusion
|
Dipti Kapoor, Preeti Singh and
*Anju Seth
Department of Pediatrics, Lady Hardinge Medical
College, New Delhi, India.
Email: [email protected]
|
N eonatal hyperbilirubinemia
(NNH) continues to be an important cause of hospital admission in the
early neonatal period. The November 1967 issue of Indian Pediatrics
had an article on "experience with exchange transfusion in the
neonates." Through this communication, we present the advances and the
current perspective on exchange transfusion in the management of
neonatal hyperbilirubinemia.
The Past
The study by Mammen KC [1], published in November
1967 issue of Indian Pediatrics, is a retrospective review of
records of 27 exchange transfusions (ET) done on 21 infants admitted in
Christian Medical college, Vellore from 1964-1965. Of 3686 live-births,
non-hemolytic hyperbilirubinemia was reported in 30 mature and 35
premature infants while 24 neonates had hemolytic disease (11 Rh
incompatibility, 13 ABO incompatibility). The ET was performed in 4 of
30 mature and 4 of 35 immature neonates with non-hemolytic
hyperbilirubinemia. Among 24 cases with hemolytic disease of newborn, ET
was performed in 9 of 11 cases with Rh incompatibility and 4 of 13 cases
with ABO incompatibility. There were 3 deaths reported (1 established
kernicterus, 1 pneumonia, 1 heart failure in hydrops) but none died due
to the procedure itself.
The author highlighted a few practical points in the
technique of ET. He emphasized the use of O-negative blood (partially
packed RBC), 80 cc/pound, cross-matched with mother’s blood for ET,
unless both the mother-baby duo had the same ABO group. Strict
monitoring was recommended during the procedure keeping a tally of the
aliquots and the cycles exchanged. To prevent hypocalcemia, 1 mL of 10%
calcium gluconate was infused after every 100 mL of citrated blood
exchanged. Besides strict surgical asepsis, the use of transparent
catheter (polyvinyl feeding tube with a rounded end and side holes) for
umbilical catheterization was strongly suggested, as it enabled easy
identification of the air bubbles that can cause of air embolism if
pushed into the circulation. The clearance of blocked catheters (clots
in the circulation) using pressure was strongly reprehended. In
situations where the high venous pressure was recorded or in the
presence of heart failure, a deficit exchange was carried until the
pressure normalized. The author felt that with the above discipline, the
risk of complications due to ET can be significantly reduced.
Historical background and past knowledge: The use
of ET (also known as exsanguination, venesection, or substitution
transfusion) was foremost reported by Dr AP Hart in 1925 in a severely
jaundiced neonate with erythroblastosis fetalis. He used the sagittal
sinus for removing blood while infusing it through a peripheral venous
cut-down. Louis Diamond [2] was the pioneer to utilize the umbilical
vein for ET in 1946. He provided the complete technique and apparatus
required for performing ET. In 1963, AW Liley introduced the technique
of intrauterine and intraperitoneal transfusions in the management of
severe anemia and NNH in fetuses during mid-gestation based on the
spectrophotometric assessment of the bilirubinoid pigment in the
amniotic fluid. Jörg Schneider was the first investigator to accomplish
rhesus prophylaxis in pregnant women in 1963. Over the following years,
the role of ante-partum and post-partum rhesus prophylaxis has been
established that has significantly decreased the fetal morbidity and
mortality.
The Present
There has been a steady fall in the incidence of
severe NNH requiring ET in the current era; however, the risk of
developing acute bilirubin encephalopathy and permanent neurological
sequelae still remains [3]. ET is an effective emergency intervention to
lower the bilirubin levels in infants at high risk of bilirubin
encephalopathy. The indications of ET in infants
³ 35 weeks gestation
are as per the AAP guidelines published in 2004, while in preterms and
low birth weight neonates, the need for ET is determined by the birth
weight, gestational age and the severity of clinical sickness [4]. The
outcome of ET is dependent on many factors, including the indication and
timing of the procedure. A modified bilirubin-induced neurologic
dysfunction (BIND-M) score has been formulated to identify the neonates
with severe acute bilirubin encephalopathy requiring immediate ET to
limit or reverse adverse neurodevelopmental outcomes [5,6].
Over the past few decades, development and widespread
use of rhesus immunoglobulin, intra-uterine transfusion, improvement in
diagnostic prenatal ultrasound intensive phototherapy and intravenous
immunoglobulin, has resulted in progressive reduction for the need of
ET. Antenatal serial measurement of anti-D antibody levels, assessment
of middle cerebral artery peak systolic velocity (MCA-PSV) and serial
amniocentesis for delta OD450 can predict the risk of severe hemolytic
disease and the need of ET in a neonate.
The etiology of hyperbilirubinemia requiring ET in
current times is different from 1900s when severe Rh isoimmunization was
predominant. The most common indication for neonatal exchange
transfusion currently is hemolytic disease of the newborn due to
maternal isoimmunization to blood groups other than Rh D. Besides
hyperbilirubinemia, use of ET has been extended in the management of
conditions like nonimmune hydrops fetalis, congenital leukemia,
disseminated intravascular coagulation, sclerema neonatorum,
hyperammonemia, polycythemia, fluid and electrolyte imbalance, and
severe neonatal sepsis [7].
The method, equipment and precautions of the ET have
largely remained the same over the years, identical to the one described
by Diamond. Nowadays, we use the disposable ET tray that includes all
the necessary instruments, catheters, syringes, four-way valve, pipe
lines extension, bag of blood waste, with additional facility for
warming the donor blood in some centers. To overcome the drawbacks of
push-pull technique, Continuous Arterio-Venous Exchange (CAVE) has been
proposed as an alternative [8]. The attempts to automate the ET
technique have failed due to technical difficulties.
References
1. Mammen KC. Experience with exchange transfusions
in the neonates. Indian Pediatr.1967;4:413-7.
2. Diamond LK, Allen FH Jr, Thomas WO Jr.
Erythroblastosis fetalis. VII. Treatment with exchange transfusion. N
Engl J Med. 1951;244:39-44.
3. Slusher TM, Olusanya BO. Neonatal jaundice in low-
and middle-income countries. In: Stevenson DK, Maisels J, Watchko
J, editors. Care of the Jaundiced Neonate. New York:McGraw-Hill; 2012.
p. 263-73.
4. American Academy of Pediatrics Subcommittee on
Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn
infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316.
5. Radmacher PG, Groves FD, Owa JA, Ofovwe GE,
Amaubunos EA, Olusanya BO, et al. A modified Bilirubin-induced
neurologic dysfunction (BIND-M) algorithm is useful in evaluating
severity of jaundice in a resource-limited setting. BMC Pediatr.
2015;15:28.
6. Olusanya BO, Osibanjo FB, Ajiboye AA, Ayodele OE,
Odunsi AA, Olaifa SM, et al. A neurologic dysfunction scoring
protocol for jaundiced neonates requiring exchange transfusion. J Matern
Fetal Neonatal Med. 2017;20:1-7.
7. Pugni L, Ronchi A, Bizzarri B, Consonni D,
Pietrasanta C, Ghirardi B, et al. Exchange transfusion in the
treatment of neonatal septic shock: A ten-year experience in a neonatal
intensive care unit. Int J Mol Sci. 2016;17(5):doi:10.3390/ijms17050695.
8. Shah R, Kumar P. Continuous Arteriovenous Exchange (CAVE): A new
technique of partial exchange transfusion In: Nangia S, Sharma M
(eds). Proceedings of the XXIX Annual Convention of National Neonatology
Forum. 10–13 December; Poster Innovation/2: Ahmedabad, India, 2009, p.
122.
|
|
 |
|